Research in the Division of Colorectal Surgery includes programs in surgical quality and outcomes, clinical treatment, basic science investigations, and more.
Our Researchers
This is an accordion element with a series of buttons that open and close related content panels.
Evie Carchman, MD: Identifying new targeted therapies to combat anal cancer
Dr. Carchman studies molecular pathways, including the autophagic pathway, which result in the development of anal dysplasia and progression to anal cancer. Her team has demonstrated that topical therapy that results in autophagic induction decreases both anal cancer and anal dysplasia development in an HPV mouse model of anal cancer, and that this treatment effect correlates with the induction of autophagy. Dr. Carchman is assessing the role of autophagic induction in the prevention of squamous cell carcinoma of the anus.
Elise Lawson, MD, MSHS: Improving quality of care for surgical patients
Dr. Lawson is Executive Director of the Surgical Collaborative of Wisconsin, a state-wide surgeon-led organization that aims to optimize quality, reduce costs, and promote delivery of care that is safe, effective, equitable, and patient-centered. Dr. Lawson’s research investigates variation in the delivery of colorectal cancer care, specifically addressing disparities in access, management, and outcomes.
Latest Research News
Department of Surgery Celebrates 17th Annual Research Summit
On Thursday, Jan. 29, the Department of Surgery celebrated the 17th Annual Research Summit. The theme of this year’s summit was “Research Without Borders.” Our keynote speaker was Dr. Sandra Wong, Dean of Emory University …
General Surgery Resident Publishes Research about Burnout
Dr. Sydney Tan, general surgery resident, recently had her research, “Work Hours, Stress, and Burnout Among Resident Physicians,” published in JAMA Network Open. Dr. Tan and her research partners at the University of Wisconsin–Madison examined …
Odorico Lab Awarded Fall Research Competition Grant to Study How Engineered Stem Cell-Derived Islets Evade the Immune System
Over the last five years there have been significant advancements in the treatment of Type 1 diabetes, including the 2023 Food and Drug Administration approval of the first stem cell-derived therapy that can replace the …
- More Research posts